{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T05:01:19Z","timestamp":1704603679133},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[1999,6,1]]},"DOI":"10.1038\/sj.gt.3300916","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T16:51:09Z","timestamp":1032367869000},"page":"1120-1127","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Augmentation of local antitumor immunity in the liver by tumor vaccine modified to secrete murine interleukin 12"],"prefix":"10.1038","volume":"6","author":[{"given":"N","family":"Fuji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,6,25]]},"reference":[{"key":"BF3300916_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1006\/jsre.1997.5113","volume":"70","author":"HM Ross","year":"1997","unstructured":"Ross HM et al. Adenoviral thymidine kinase prodrug gene therapy inhibits sarcoma growth in vivo J Surg Res 1997 70: 7\u201311","journal-title":"J Surg Res"},{"key":"BF3300916_CR2","first-page":"3266","volume":"53","author":"RT Prehn","year":"1993","unstructured":"Prehn RT . Two competing influences that may explain concomitant tumor resistance Cancer Res 1993 53: 3266\u20133269","journal-title":"Cancer Res"},{"key":"BF3300916_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/ijc.2910270618","volume":"27","author":"E Gorelik","year":"1981","unstructured":"Gorelik E, Segal S, Feldman M . On the mechanism of tumor \u2018concomitant immunity\u2019 Int J Cancer 1981 27: 847\u2013856","journal-title":"Int J Cancer"},{"key":"BF3300916_CR4","first-page":"1488","volume":"43","author":"B Fisher","year":"1983","unstructured":"Fisher B, Gunduz N, Saffer EA . Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases Cancer Res 1983 43: 1488\u20131492","journal-title":"Cancer Res"},{"key":"BF3300916_CR5","first-page":"943","volume":"73","author":"S Nomi","year":"1984","unstructured":"Nomi S, Pellis NR, Kahan BD . Retardation of postsurgical metastases with the use of extracted tumor-specific transplantation antigens and cyclophosphamide J Natl Cancer Inst 1984 73: 943\u2013950","journal-title":"J Natl Cancer Inst"},{"key":"BF3300916_CR6","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4049\/jimmunol.146.3.1077","volume":"146","author":"T Tada","year":"1991","unstructured":"Tada T et al. Transforming growth factor-\u03b2-induced inhibition of T cell function: susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state J Immunol 1991 146: 1077\u20131082","journal-title":"J Immunol"},{"key":"BF3300916_CR7","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.154.5.2281","volume":"154","author":"N Yamamoto","year":"1995","unstructured":"Yamamoto N et al. Regulatory mechanisms for production of IFN-\u03b3 and TNF by antitumor T cells or macrophages in the tumor-bearing state J Immunol 1995 154: 2281\u20132290","journal-title":"J Immunol"},{"key":"BF3300916_CR8","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1089\/hum.1997.8.14-1667","volume":"8","author":"DS Chen","year":"1997","unstructured":"Chen DS et al. Retroviral vector-mediated transfer of an antisense cyclin G1 construct inhibits osteosarcoma tumor growth in nude mice Hum Gene Ther 1997 8: 1667\u20131674","journal-title":"Hum Gene Ther"},{"key":"BF3300916_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/0167-5699(94)90131-7","volume":"15","author":"MP Colombo","year":"1994","unstructured":"Colombo MP, Forni G . Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol Today 1994 15: 48\u201351","journal-title":"Immunol Today"},{"key":"BF3300916_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1006\/meth.1997.0463","volume":"12","author":"EM Jaffee","year":"1997","unstructured":"Jaffee EM, Pardoll DM . Considerations for the clinical development of cytokine gene-transduced tumor cell vaccines Methods 1997 12: 143\u2013153","journal-title":"Methods"},{"key":"BF3300916_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/BF01517213","volume":"41","author":"MP Colombo","year":"1995","unstructured":"Colombo MP, Rodolfo M . Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials? Cancer Immunol Immunother 1995 41: 265\u2013270","journal-title":"Cancer Immunol Immunother"},{"key":"BF3300916_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0952-7915(96)80076-8","volume":"8","author":"DM Pardoll","year":"1996","unstructured":"Pardoll DM . Cancer vaccines: a road map for the next decade Curr Opin Immunol 1996 8: 619\u2013621","journal-title":"Curr Opin Immunol"},{"key":"BF3300916_CR13","first-page":"467","volume":"56","author":"M Vagliani","year":"1996","unstructured":"Vagliani M et al. Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells Cancer Res 1996 56: 467\u2013470","journal-title":"Cancer Res"},{"key":"BF3300916_CR14","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/eji.1830260624","volume":"26","author":"L Zitvogel","year":"1996","unstructured":"Zitvogel L et al. Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors Eur J Immunol 1996 26: 1335\u20131341","journal-title":"Eur J Immunol"},{"key":"BF3300916_CR15","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1073\/pnas.95.5.2475","volume":"95","author":"HN Lode","year":"1998","unstructured":"Lode HN et al. Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma Proc Natl Acad Sci USA 1998 95: 2475\u20132480","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3300916_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1084\/jem.170.3.827","volume":"170","author":"M Kobayashi","year":"1989","unstructured":"Kobayashi M et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes J Exp Med 1989 170: 827\u2013845","journal-title":"J Exp Med"},{"key":"BF3300916_CR17","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.1073\/pnas.87.17.6808","volume":"87","author":"AS Stern","year":"1990","unstructured":"Stern AS et al. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells Proc Natl Acad Sci USA 1990 87: 6808\u20136812","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3300916_CR18","doi-asserted-by":"crossref","first-page":"874","DOI":"10.4049\/jimmunol.147.3.874","volume":"147","author":"MK Gately","year":"1991","unstructured":"Gately MK et al. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor) J Immunol 1991 147: 874\u2013882","journal-title":"J Immunol"},{"key":"BF3300916_CR19","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.4049\/jimmunol.146.9.3074","volume":"146","author":"SF Wolf","year":"1991","unstructured":"Wolf SF et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells J Immunol 1991 146: 3074\u20133081","journal-title":"J Immunol"},{"key":"BF3300916_CR20","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4049\/jimmunol.148.11.3433","volume":"148","author":"DS Schoenhaut","year":"1992","unstructured":"Schoenhaut DS et al. Cloning and expression of murine IL-12 J Immunol 1992 148: 3433\u20133440","journal-title":"J Immunol"},{"key":"BF3300916_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/intimm\/6.1.157","volume":"6","author":"MK Gately","year":"1994","unstructured":"Gately MK et al. Administration of recombinant IL-12 to normal mice enhances the cytolytic lymphocyte activity and induces production of IFN-\u03b3 in vivo Intern Immunol 1994 6: 157\u2013167","journal-title":"Intern Immunol"},{"key":"BF3300916_CR22","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1084\/jem.178.4.1223","volume":"178","author":"MJ Brunda","year":"1993","unstructured":"Brunda MJ et al. Antitumor and antimetastatic activity of interleukin 12 against murine tumors J Exp Med 1993 178: 1223\u20131230","journal-title":"J Exp Med"},{"key":"BF3300916_CR23","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.4049\/jimmunol.154.9.4333","volume":"154","author":"W Hashimoto","year":"1995","unstructured":"Hashimoto W et al. Cytotoxic NK1.1 Ag+ \u03b1\u03b2 T cells with intermediate TCR induced in the liver of mice by IL-12 J Immunol 1995 154: 4333\u20134340","journal-title":"J Immunol"},{"key":"BF3300916_CR24","first-page":"1281","volume":"41","author":"IR Hart","year":"1981","unstructured":"Hart IR, Talmadge JE, Fidler IJ . Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth Cancer Res 1981 41: 1281\u20131287","journal-title":"Cancer Res"},{"key":"BF3300916_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/BF01741748","volume":"34","author":"G Acerbis","year":"1992","unstructured":"Acerbis G et al. Postsurgical adjuvant chemoimmunotherapy with recombinant interleukin-2 and 1,3-bis-(2-chloroethyl)-1-nitrosurea on spontaneous metastases of a non-immunogenic murine tumour Cancer Immunol Immunother 1992 34: 383\u2013388","journal-title":"Cancer Immunol Immunother"},{"key":"BF3300916_CR26","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.4049\/jimmunol.156.9.3366","volume":"156","author":"K Takeda","year":"1996","unstructured":"Takeda K et al. Liver NK1.1+ CD4+ \u03b1\u03b2 T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis J Immunol 1996 156: 3366\u20133373","journal-title":"J Immunol"},{"key":"BF3300916_CR27","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","volume":"90","author":"G Dranoff","year":"1993","unstructured":"Dranoff G et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte\u2013macrophage colony-stimulating factor stimulates potent, specific and long-lasting anti-tumor immunity Proc Natl Acad Sci USA 1993 90: 3539\u20133543","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3300916_CR28","first-page":"3679","volume":"52","author":"A Porgador","year":"1992","unstructured":"Porgador A et al. Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells Cancer Res 1992 52: 3679\u20133686","journal-title":"Cancer Res"},{"key":"BF3300916_CR29","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1084\/jem.173.4.889","volume":"173","author":"MP Colombo","year":"1991","unstructured":"Colombo MP et al. Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo J Exp Med 1991 173: 889\u2013897","journal-title":"J Exp Med"},{"key":"BF3300916_CR30","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.4049\/jimmunol.157.12.5536","volume":"157","author":"M Rodolfo","year":"1996","unstructured":"Rodolfo M et al. Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens J Immunol 1996 157: 5536\u20135542","journal-title":"J Immunol"},{"key":"BF3300916_CR31","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1126\/science.7770767","volume":"268","author":"SS Hall","year":"1995","unstructured":"Hall SS . IL-12 at the crossroads Science 1995 268: 1432\u20131434","journal-title":"Science"},{"key":"BF3300916_CR32","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1126\/science.268.5217.1555","volume":"268","author":"E Marshall","year":"1995","unstructured":"Marshall E . Cancer trial of interleukin-12 halted Science 1995 268: 1555","journal-title":"Science"},{"key":"BF3300916_CR33","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1126\/science.278.5343.1623","volume":"278","author":"J Cui","year":"1997","unstructured":"Cui J et al. Requirement for V\u03b114 NKT cells in IL-12-mediated rejection of tumors Science 1997 278: 1623\u20131626","journal-title":"Science"},{"key":"BF3300916_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1046\/j.1365-2567.1996.d01-638.x","volume":"88","author":"R Anzai","year":"1996","unstructured":"Anzai R et al. Interleukin-12 induces cytotoxic NK1+ \u03b1\u03b2 T cells in the lungs of euthymic and athymic mice Immunology 1996 88: 82\u201389","journal-title":"Immunology"},{"key":"BF3300916_CR35","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.4049\/jimmunol.153.4.1697","volume":"153","author":"CL Nastala","year":"1994","unstructured":"Nastala CL et al. Recombinant IL-12 administration induces tumor regression in association with IFN-\u03b3 production J Immunol 1994 153: 1697\u20131706","journal-title":"J Immunol"},{"key":"BF3300916_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/eji.1830250124","volume":"25","author":"A Martinotti","year":"1995","unstructured":"Martinotti A et al. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes Eur J Immunol 1995 25: 137\u2013146","journal-title":"Eur J Immunol"},{"key":"BF3300916_CR37","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1073\/pnas.92.7.2577","volume":"92","author":"SH Chen","year":"1995","unstructured":"Chen SH et al. Combination gene therapy for liver metastasis of colon carcinoma in vivo Proc Natl Acad Sci USA 1995 92: 2577\u20132581","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3300916_CR38","doi-asserted-by":"publisher","first-page":"8915","DOI":"10.1073\/pnas.91.19.8915","volume":"91","author":"DW Russell","year":"1994","unstructured":"Russell DW, Miller AD, Alexander IE . Adeno-associated virus vectors preferentially transduce cells in S phase Proc Natl Acad Sci USA 1994 91: 8915\u20138919","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3300916_CR39","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1128\/jvi.68.9.5656-5666.1994","volume":"68","author":"G Podsakoff","year":"1994","unstructured":"Podsakoff G, Wong KK Jr, Chatterjee S . Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors J Virol 1994 68: 5656\u20135666","journal-title":"J Virol"},{"key":"BF3300916_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1084\/jem.182.1.155","volume":"182","author":"AL Angiolillo","year":"1995","unstructured":"Angiolillo AL et al. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo J Exp Med 1995 182: 155\u2013162","journal-title":"J Exp Med"},{"key":"BF3300916_CR41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4049\/jimmunol.156.2.693","volume":"156","author":"CS Tannenbaum","year":"1996","unstructured":"Tannenbaum CS et al. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12 J Immunol 1996 156: 693\u2013699","journal-title":"J Immunol"},{"key":"BF3300916_CR42","first-page":"1225","volume":"58","author":"P Nanni","year":"1998","unstructured":"Nanni P et al. Interleukin 12 gene therapy of MHC-negative murine melanoma metastases Cancer Res 1998 58: 1225\u20131230","journal-title":"Cancer Res"},{"key":"BF3300916_CR43","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.4049\/jimmunol.154.12.6466","volume":"154","author":"H Tahara","year":"1995","unstructured":"Tahara H et al. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector J Immunol 1995 154: 6466\u20136474","journal-title":"J Immunol"},{"key":"BF3300916_CR44","first-page":"182","volume":"54","author":"H Tahara","year":"1994","unstructured":"Tahara H et al. Fibroblasts genetically engineered to secrete interleukin-12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo Cancer Res 1994 54: 182\u2013189","journal-title":"Cancer Res"},{"key":"BF3300916_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0022-1759(92)90223-G","volume":"146","author":"H Watanabe","year":"1992","unstructured":"Watanabe H et al. Details of an isolation method for hepatic lymphocytes in mice J Immunol Meth 1992 146: 145\u2013154","journal-title":"J Immunol Meth"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3300916.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3300916","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3300916.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T01:23:44Z","timestamp":1704590624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3300916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6,1]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,6,1]]}},"alternative-id":["BF3300916"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3300916","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,6,1]]},"assertion":[{"value":"4 November 1998","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 1999","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 1999","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}